Publication: Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program
Program
KU-Authors
KU Authors
Co-Authors
Stern C, Loustaud-Ratti V, Yurdaydin C, Brancaccio G, Jachs M, Reiberger T, Bardou-Jacquet E, Metivier S, Alric L, Colombain L, Meszaros M, Mathurin P, Yardeni D, Etzion O, Neumann-Haefelin C, Douglas M, Poulin S, Bazinet M, Metin RO, Vitale A, Gaeta GB, Schwarz M, Ben-Ali S, Bedoya JU, Testoni B, Zoulim F, Plissonnier ML, Levrero M, Paradis V, Francois S, de Freitas C, Kaysin F, Lecomte L, Morvan C, Schramko J, Bondezi K, Baril MÉ, Brichler S, Gerber A, Gordien E, Mackiewicz V, Dahari H, Svicher V, Chevaliez S, Vaillant A, Bourliere M.
Publication Date
Language
Type
Embargo Status
No
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Source
Publisher
Subject
Citation
Has Part
Source
J Hepatol
Book Series Title
Edition
DOI
10.1016/j.jhep.2025.10.029
item.page.datauri
Link
Rights
CC BY-NC-ND (Attribution-NonCommercial-NoDerivs)
Copyrights Note
Creative Commons license
Except where otherwised noted, this item's license is described as CC BY-NC-ND (Attribution-NonCommercial-NoDerivs)